Stockscreener 앱 받기
90.36
0.78%
-0.71
시간 외 거래:
90.36
전일 마감가:
$91.07
열려 있는:
$91.07
하루 거래량:
2.47M
Relative Volume:
1.22
시가총액:
$11.85B
수익:
$982.02M
순이익/손실:
$-416.28M
주가수익비율:
-27.26
EPS:
-3.3148
순현금흐름:
$-233.07M
1주 성능:
+4.58%
1개월 성능:
+6.08%
6개월 성능:
+33.85%
1년 성능:
+112.06%
1일 변동 폭
$90.28
$95.18
1주일 범위
$83.39
$95.18
52주 변동 폭
$36.36
$120.74
가든트헬스 Stock (GH) Company Profile
명칭
Guardant Health Inc
전화
855-698-8887
주소
3100 HANOVER STREET, PALO ALTO
Compare GH vs TMO, DHR, IDXX, A, WAT
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GH
Guardant Health Inc
|
90.36 | 11.95B | 982.02M | -416.28M | -233.07M | -3.3148 |
TMO
Thermo Fisher Scientific Inc
|
524.57 | 195.48B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
194.54 | 138.36B | 24.57B | 3.60B | 5.26B | 5.051 |
IDXX
Idexx Laboratories Inc
|
569.01 | 46.31B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
122.09 | 34.18B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
335.23 | 32.95B | 3.17B | 642.63M | 516.49M | 10.77 |
가든트헬스 Stock (GH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-20 | 재확인 | Canaccord Genuity | Buy |
| 2026-02-17 | 개시 | Robert W. Baird | Outperform |
| 2026-01-05 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2025-12-02 | 재개 | Morgan Stanley | Overweight |
| 2025-09-25 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2025-09-22 | 재개 | Wells Fargo | Overweight |
| 2025-04-10 | 개시 | Mizuho | Outperform |
| 2025-01-23 | 개시 | Barclays | Overweight |
| 2024-06-28 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2024-06-03 | 재개 | Jefferies | Buy |
| 2024-04-24 | 재개 | Craig Hallum | Buy |
| 2023-12-14 | 개시 | Guggenheim | Neutral |
| 2023-12-13 | 개시 | Wolfe Research | Peer Perform |
| 2023-11-13 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2023-09-28 | 개시 | Bernstein | Outperform |
| 2023-09-27 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2023-07-05 | 재개 | JP Morgan | Overweight |
| 2023-05-26 | 업그레이드 | Citigroup | Neutral → Buy |
| 2023-05-05 | 개시 | UBS | Buy |
| 2023-03-09 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2023-01-05 | 개시 | Scotiabank | Sector Outperform |
| 2022-11-01 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-10-19 | 개시 | Craig Hallum | Buy |
| 2022-10-06 | 개시 | Stephens | Overweight |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2022-06-03 | 개시 | Piper Sandler | Overweight |
| 2022-04-28 | 재개 | BTIG Research | Buy |
| 2022-02-24 | 재확인 | Canaccord Genuity | Buy |
| 2022-02-24 | 재확인 | Citigroup | Buy |
| 2022-02-24 | 재확인 | Cowen | Outperform |
| 2022-02-24 | 재확인 | Morgan Stanley | Overweight |
| 2022-02-24 | 재확인 | SVB Leerink | Outperform |
| 2022-02-24 | 재확인 | Stifel | Buy |
| 2022-02-24 | 재확인 | Wells Fargo | Overweight |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-06-15 | 개시 | Raymond James | Mkt Perform |
| 2021-06-03 | 개시 | Goldman | Buy |
| 2021-05-25 | 개시 | Wells Fargo | Overweight |
| 2021-01-11 | 개시 | Stifel | Buy |
| 2020-09-09 | 개시 | Morgan Stanley | Overweight |
| 2020-06-12 | 개시 | BTIG Research | Buy |
| 2020-02-21 | 개시 | Guggenheim | Buy |
| 2020-01-07 | 개시 | Citigroup | Buy |
| 2019-08-07 | 재확인 | Canaccord Genuity | Buy |
| 2019-04-16 | 개시 | Canaccord Genuity | Buy |
| 2019-04-10 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-02-28 | 재확인 | BofA/Merrill | Neutral |
| 2018-10-29 | 개시 | BofA/Merrill | Neutral |
| 2018-10-29 | 개시 | JP Morgan | Overweight |
| 2018-10-29 | 개시 | William Blair | Outperform |
모두보기
가든트헬스 주식(GH)의 최신 뉴스
Price-Driven Insight from (GH) for Rule-Based Strategy - Stock Traders Daily
Guardant Health director exercises 232 RSUs into shares | GH Insider Trading - Stock Titan
Biopsy Devices Market 2026- 2033 Overview: Share, Size, Value, - openPR.com
Guardant Health, Inc. (NASDAQ:GH) Sees Large Growth in Short Interest - MarketBeat
Guardant Health to Report First Quarter 2026 Financial Results on May 7, 2026 - BioSpace
Tariq Musa, Guardant Health director, sells $9840 in stock By Investing.com - Investing.com Australia
Tariq Musa, Guardant Health director, sells $9840 in stock - Investing.com
Guardant Health (GH) director sells 116 shares after RSU conversion - Stock Titan
Guardant Health (GH) CLO RSUs Vest with Shares Withheld for Tax Obligations - Stock Titan
9,840-share Form 144 sale by Guardant Health (NASDAQ: GH) - Stock Titan
Piper Sandler Maintains Guardant Health(GH.US) With Buy Rating, Maintains Target Price $130 - Moomoo
Piper Sandler reiterates Guardant Health stock rating on ctDNA data By Investing.com - Investing.com Canada
Guardant Health: As April marks National Cancer Prevention and Early Detection Month, FDA-approved blood test for colorectal cancer screening makes it easier to screen in Wisconsin - WisBusiness
Guardant Health, Inc. $GH Position Cut by Massachusetts Financial Services Co. MA - MarketBeat
Guardant Health real-world data supports Japan approval of ENHERTU for HER2-positive tumors - MSN
Sumitomo Mitsui Trust Group Inc. Sells 113,649 Shares of Guardant Health, Inc. $GH - MarketBeat
GH Stock Price, Quote & Chart | GUARDANT HEALTH INC (NASDAQ:GH) - ChartMill
Will Guardant Health (GH) Report Negative Earnings Next Week? What You Should Know - Eastern Progress
Barclays Maintains Guardant Health(GH.US) With Buy Rating, Cuts Target Price to $115 - Moomoo
Mizuho Securities Maintains Guardant Health(GH.US) With Buy Rating, Maintains Target Price $135 - Moomoo
TD Cowen cuts Guardant Health stock price target on valuation By Investing.com - Investing.com Canada
Guardant Health, Inc. $GH Holdings Lowered by Baillie Gifford & Co. - MarketBeat
Cloudflare, ServiceNow, And Guardant Health Are Among Top 10 Large-Cap Losers Last Week (April 6-April 10 - Benzinga
Oscar, Guardant, Redwire, Gap, AFLAC: Insider Moves Shock Wall Street - TipRanks
Guardant Health Surges to $510 Million in Trading Volume as Insiders and Institutional Investors Dispute Over $81 Share Price - Bitget
Guardant Health (NASDAQ:GH) Shares Down 7%Time to Sell? - MarketBeat
(GH) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Guardant Health (GH) partners with Manulife to launch Shield multi-cancer detection test in Asia - MSN
Guardant Health Inc (GH) Stock Price Down 4.62% on Apr 9 - GuruFocus
Why Guardant Health’s (GH) 2026 screening story reinforced Piper Sandler’s bullish view - MSN
US Market Recap: Is now the right time to enter Guardant Health IncEarnings Miss & Community Consensus Stock Picks - baoquankhu1.vn
Multi-Cancer Early Detection Testing Market to Reach USD 7.52 - openPR.com
Aberdeen Group Trims Stake in Guardant Health - National Today
Aberdeen Group plc Sells 40,577 Shares of Guardant Health, Inc. $GH - MarketBeat
Aug Summary: Can Guardant Health Inc keep up with sector leaders2026 Catalysts & High Conviction Buy Zone Picks - baoquankhu1.vn
OS Therapies Appoints Craig Eagle, MD as Strategic Advisor - Yahoo Finance
Analysts Offer Insights on Healthcare Companies: Neurocrine (NBIX), Guardant Health (GH) and Compass Therapeutics (CMPX) - The Globe and Mail
Insider Sell: Terilyn Monroe Sells Shares of Guardant Health Inc (GH) - GuruFocus
Guardant Health (GH) chief people officer sells $355k in stock - Investing.com India
Guardant Health Insider Sells $355K in Shares - National Today
Guardant Health (GH) chief people officer sells $355k in stock By Investing.com - Investing.com South Africa
Guardant Health (GH) Chief People Officer sells 3,832 shares in open market - Stock Titan
CCORF Maintains Guardant Health(GH.US) With Buy Rating, Maintains Target Price $135 - Moomoo
Guardant Health (GH) Positioned for Potential Upside, Says Citi - GuruFocus
Canaccord reiterates Guardant Health stock rating on cancer test growth - Investing.com
How does Guardant Health Inc compare to its peers2026 Biggest Moves & Risk Managed Investment Strategies - baoquankhu1.vn
Guardant Health, Inc. (GH) Stock Price, News, Quote & History - Yahoo! Finance Canada
Guardant Health (GH) Sees Price Target Reduction from Evercore I - GuruFocus
Guardant Health, Organon, Fortrea, QuidelOrtho, and Charles River Laboratories Stocks Trade Down, What You Need To Know - Yahoo Finance
Guardant Health: Leveraging Liquid Biopsy Testing Momentum (NASDAQ:GH) - Seeking Alpha
[144] Guardant Health, Inc. SEC Filing - Stock Titan
가든트헬스 (GH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.57%
0.03%
자본화:
|
볼륨(24시간):